Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer

Lee, Joy S.Y.; Grant, Clive S.; Donohue, John H.; Crotty, Tom; Harmsen, William S.; Ilstrup, Duane M.

doi:10.1016/s0039-6060(05)80030-3

Cited by 51 publications

(19 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…First, many studies [11][12][13][14][15][16][17][18][19] have evaluated the effect of bilateral breast carcinoma on outcome. Most of these studies ( Table 6) have revealed that survival is determined by the biology of the first tumor, and a contralateral cancer does not appear to worsen the prognosis.…”

Section: Discussionmentioning

confidence: 99%

A case-control study of unilateral and bilateral breast carcinoma patients

Newman

Sahin

Bondy

et al. 2001

Cancer

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

A case-control study of unilateral and bilateral breast carcinoma patients

Newman

Sahin

Bondy

et al. 2001

Cancer

View full text Add to dashboard Cite

“…A 10% cumulative risk of contralateral breast cancer at 10 years in women with ILC has been reported. 18 Recent data, however, suggest a similar incidence of contralateral cancer between invasive lobular and invasive ductal carcinomas. 16,34 -36 Although considered a marker of increased risk, lobular carcinoma in situ has been associated with an increased incidence of contralateral breast disease in women with breast cancer.…”

Section: Physician Indications For Cpmmentioning

confidence: 99%

Issues of Regret in Women With Contralateral Prophylactic Mastectomies

et al. 1999

View full text Add to dashboard Cite

show abstract

“…Another study evaluated 105 patients with known unilateral infiltrating lobular carcinoma undergoing contralateral prophylactic mastectomy. In this study group 7 (6.6%) were found to have in situ carcinomas and 4 (3.8%) were found to have invasive carcinomas (2). The occurrence of metachronous breast cancer has been shown to occur at a rate of 0.5-1 YO per year up to 20 years of follow-up (2)(3)(4).…”

Section: Synchronous and Metachronous Contralateral Breast Cancermentioning

confidence: 73%

Prophylactic Mastectomy

Simmons

Osborne

1997

Breast Journal

View full text Add to dashboard Cite

W Abstract: Prophylactic mastectomy may be an appropriate treatment for several groups of women. These groups include women with a strong family history of breast cancer, especially those with known BRCA mutations, women with high risk pathologic changes found on previous breast biopsies, women with an immobilizing fear of developing breast cancer, and women with contralateral breast cancer. The effectiveness of prophylactic mastectomy is controversial although recent data suggests a possible gain in life expectancy for high risk women undergoing bilateral prophylactic mastectomy. Each woman should have a thorough discussion with her treatment team, which should include a oncologic surgeon, plastic surgeon, psychologist, and genetic counselor, to realistically assess her risk due to family history, genetic mutations, or high risk pathologic findings, as well as the expectations and limitations of prophylactic mastectomy. W Key Words: prophylactic mastectomy, high risk, preventive surgery, breast cancer genetics ne of the most controversial surgical procedures 0 today is the prophylactic mastectomy, which removes the breast when there is no known disease present in the hope of preventing future breast cancer. Much of the controversy has revolved around the question of how much the risk is reduced and for whom is Address all correspondence and reprint requests to: Rache M. Simmons, M.D., 428 East 72nd Street, New York, NY 10021, U.S.A. 0 I997 Bluckwell Scwnce Inc., 1075-122X/~7/$10.50/0 rhp Breust /oi4rtztil. Volume 3, Nicmher 6, 1997 372-379the procedure appropriate. There are two groups of women who may consider this procedure: those who have breast cancer in one breast and choose to have the opposite normal breast removed, a contralateral prophylactic mastectomy (CPM); and those who do not have breast cancer and choose to have both normal breasts removed, bilateral prophylactic mastectomies (BPM). The majority of women who consider BPM are those a t increased risk of developing breast cancer. This group includes those with a strong family history of breast cancer or those with high-risk lesions such as lobular neoplasia (lobular carcinoma in situ) or atypical ductal/lobular epithelial hyperplasia observed on a previous biopsy. Recently, the discovery of the BRCA-1 and BRCA-2 breast cancer genetic mutations and the availability to test for the presence of these mutations, will lead to a significant new group of women considering this procedure. Another group of women that may consider BPM are those with an incapacitating fear of developing breast cancer, such that it adversely affects their quality of life. For women considering prophylactic mastectomy it is a complex risk:benefit ratio. The potential benefit depends on the risk of breast cancer, the outcome if cancer were to occur, the surgical procedure and its complications in relation to potential benefits of risk reduction. Some women are unwilling to accept close follow-up surveillance with the hope of early detection as their defense against breast cancer ...

show abstract

Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer

Cited by 51 publications

References 19 publications

A case-control study of unilateral and bilateral breast carcinoma patients

A case-control study of unilateral and bilateral breast carcinoma patients

Issues of Regret in Women With Contralateral Prophylactic Mastectomies

Prophylactic Mastectomy

Contact Info

Product

Resources

About